RCKT (Rocket Pharmaceuticals, Inc.) Stock Financials & Earnings | Market Cap Arena

RCKT (Rocket Pharmaceuticals, Inc.) Stock Financials & Earnings | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

Mkt Cap$572M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$223M

EPS (TTM)-$2.01

Free Cash Flow (TTM)-$190M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$62M
Q2 23	$0	$0	-$69M
Q3 23	$0	$0	-$65M
Q4 23	$0	$0	-$63M
Q1 24	$0	-$2M	-$67M
Q2 24	$0	-$2M	-$74M
Q3 24	$0	$0	-$69M
Q4 24	$0	$0	-$63M
Q1 25	$0	$0	-$64M
Q2 25	$0	$0	-$71M
Q3 25	$0	$0	-$52M
Q4 25	$0	$0	-$44M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$58M	-$61M
Q2 23	-$51M	-$55M
Q3 23	-$57M	-$62M
Q4 23	-$29M	-$34M
Q1 24	-$57M	-$59M
Q2 24	-$54M	-$56M
Q3 24	-$52M	-$54M
Q4 24	-$47M	-$47M
Q1 25	-$56M	-$56M
Q2 25	-$49M	-$49M
Q3 25	-$50M	-$50M
Q4 25	-$35M	-$35M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$3M
Q2 23	$4M
Q3 23	$5M
Q4 23	$5M
Q1 24	$2M
Q2 24	$2M
Q3 24	$2M
Q4 24	$309K
Q1 25	$364K
Q2 25	$50K
Q3 25	$54K
Q4 25	$80K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+46.1%
Q2 23	—	+26.8%
Q3 23	—	+11.9%
Q4 23	—	-8.4%
Q1 24	—	+8.3%
Q2 24	—	+7.2%
Q3 24	—	+6.1%
Q4 24	—	-0.9%
Q1 25	—	-4.4%
Q2 25	—	-3.5%
Q3 25	—	-24.7%
Q4 25	—	-29.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$9M	—
Q2 23	$10M	—
Q3 23	$10M	—
Q4 23	$0	—
Q1 24	$10M	—
Q2 24	$11M	—
Q3 24	$11M	—
Q4 24	$11M	—
Q1 25	$10M	—
Q2 25	$11M	—
Q3 25	$10M	—
Q4 25	$6M	—

OpEx Breakdown

Quarter	R&D	G&A
Q1 23	$46M	$16M
Q2 23	$51M	$17M
Q3 23	$47M	$19M
Q4 23	$42M	$22M
Q1 24	$44M	$22M
Q2 24	$45M	$27M
Q3 24	$42M	$27M
Q4 24	$37M	$25M
Q1 25	$36M	$28M
Q2 25	$43M	$25M
Q3 25	$34M	$18M
Q4 25	$29M	$15M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$65M	$267M	$331M
Q2 23	$45M	$262M	$307M
Q3 23	$226M	$212M	$437M
Q4 23	$56M	$317M	$373M
Q1 24	$35M	$295M	$330M
Q2 24	$39M	$240M	$279M
Q3 24	$66M	$170M	$236M
Q4 24	$164M	$209M	$372M
Q1 25	$50M	$268M	$318M
Q2 25	$33M	$239M	$271M
Q3 25	$76M	$147M	$223M
Q4 25	$78M	$0	$78M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	79M	+9.0%
Q2 23	80M	+1.3%
Q3 23	83M	+2.7%
Q4 23	93M	+12.9%
Q1 24	94M	+0.2%
Q2 24	94M	+0.2%
Q3 24	94M	+0.4%
Q4 24	98M	+3.6%
Q1 25	110M	+12.9%
Q2 25	111M	+0.8%
Q3 25	112M	+0.5%
Q4 25	111M	-0.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$0	5
FY 15	$0	17
FY 16	$0	24
FY 17	$0	20
FY 18	$0	33
FY 19	$0	57
FY 20	$0	91
FY 21	$0	151
FY 22	$0	240
FY 23	$0	268
FY 24	$0	299
FY 25	$0	200K